As already observed (Fig 1), the reduced tumor growth of the KRAS-knockdown cells was reversed by re-expressing shRNA-resistant wild-type Flag-KRAS, as these cells formed significantly larger (7.3 fold) tumors than the KRAS-knockdown cells. The gene discussed is KRAS; the disease is neoplasm.